IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
1.880
+0.042 (2.29%)
Oct 13, 2026, 3:12 PM CET
Revenue by Segment
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.